'Mad Money' host Jim Cramer weighs in on stocks including: Lockheed Martin, ADMA Biologics, Novocure, and Keysight. Posted: ...

NovoCure (NVCR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Emily Bodnar from H.C. Wainwright maintained a Buy rating on the stock and ...

$110,000 of NOVOCURE INC. lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "General Medicare Issues. H.R.1691/S.

New headquarters supports Novocure’s continued growth as it pursues its mission of extending survival in some of the most aggressive forms of cancer BAAR, Switzerland, January 22, 2025 ...

From the beginning of 2024 through Dec. 3, shares of Novocure rose 112% higher. They've been soaring because, in addition to positive pancreatic cancer results, its Optune Lua device earned ...

Cancer-targeting biotech NovoCure (NASDAQ: NVCR) had some highly positive news from the laboratory to deliver earlier this week, and investors couldn't grab hold of the stock fast enough.

Novocure (NVCR) announced the official opening of its new global headquarters in the Canton of Zug, Switzerland. Published first on TheFly – the ultimate source for real-time, market-moving ...

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor ...

Investing.com -- Novocure Ltd (NASDAQ:NVCR) shares soared sharply after the announcement that the FDA had approved Optune Lua ...

Novocure (NASDAQ: NVCR) today reported preliminary unaudited financial and operational results for the quarter and full year ended December 31, 2024. Novocure is a global oncology company working ...

It might be of some concern to shareholders to see the NovoCure Limited ( NASDAQ:NVCR ) share price down 15% in ...

In the latest quarter, 7 analysts provided ratings for NovoCure NVCR, showcasing a mix of bullish and bearish perspectives. The table below provides a snapshot of their recent ratings, showcasing ...